Terumo Buying Organ Tech Provider OrganOx for $1.5 Billion

Terumo Corporation, a leading medical device company, has announced the acquisition of UK-based OrganOx Ltd., a provider of organ medical technology, for a total value of approximately $1.5 billion. This strategic move by Terumo aims to expand its presence in the organ transplant market. OrganOx is known for its innovative technology that helps preserve and assess the viability of organs, particularly livers, prior to transplantation. This acquisition will allow Terumo to leverage OrganOx's expertise and technology to strengthen its position in the growing organ transplant field, which is expected to witness increasing demand due to the rising incidence of organ failure. The deal is subject to regulatory approvals and is expected to be completed by the end of 2023. This acquisition represents a significant investment by Terumo as it seeks to diversify its portfolio and capitalize on the growing demand for advanced medical solutions in the organ transplant sector.